BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Sophia S. Wang, M. Concepcion Bratti, Ana Cecilia Rodríguez, Rolando Herrero, Robert D. Burk, Carolina Porras, Paula González, Mark E. Sherman, Sholom Wacholder, Z. Elizabeth Lan, Mark Schiffman, Stephen J. Chanock, Allan Hildesheim. Common Variants in Immune and DNA Repair Genes and Risk for Human Papillomavirus Persistence and Progression to Cervical CancerJournal of Infectious Diseases 2009; 199(1): 20 doi: 10.1086/595563
2
Zhi Li, Hong Yao, Yan Ma, Qingming Dong, Yangchao Chen, Ying Peng, Bo-jian Zheng, Jian-dong Huang, Chu-yan Chan, Marie C. Lin, Joseph J Sung, Kwok Yun Yuen, Hsiang-fu Kung, Ming-Liang He. Inhibition of HBV gene expression and replication by stably expressed interferon-α1 via adeno-associated viral vectorsThe Journal of Gene Medicine 2008; 10(6): 619 doi: 10.1002/jgm.1174
3
Daniel P Webster, Paul Klenerman, Jane Collier, Katie JM Jeffery. Development of novel treatments for hepatitis CThe Lancet Infectious Diseases 2009; 9(2): 108 doi: 10.1016/S1473-3099(09)70020-9
4
Pasi Kaukinen, Maarit Sillanpää, Laura Nousiainen, Krister Melén, Ilkka Julkunen. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functionsJournal of Medical Virology 2013; 85(1): 71 doi: 10.1002/jmv.23442
5
Kazuaki Inoue, Kyoko Tsukiyama-Kohara, Chiho Matsuda, Mitsutoshi Yoneyama, Takashi Fujita, Shusuke Kuge, Makoto Yoshiba, Michinori Kohara. Impairment of interferon regulatory factor-3 activation by hepatitis C virus core protein basic amino acid region 1Biochemical and Biophysical Research Communications 2012; 428(4): 494 doi: 10.1016/j.bbrc.2012.10.079
6
Tomoh Matsumiya, Tadaatsu Imaizumi, Hidemi Yoshida, Kei Satoh. Antiviral Signaling Through Retinoic Acid-Inducible Gene-I-Like ReceptorsArchivum Immunologiae et Therapiae Experimentalis 2011; 59(1): 41 doi: 10.1007/s00005-010-0107-9
7
Premashis Kar, Deepak Kumar, Phani Kumar Gumma, Soumya Jyoti Chowdhury, Vijay Kumar Karra. Down regulation of TRIF, TLR3, and MAVS in HCV infected liver correlates with the outcome of infectionJournal of Medical Virology 2017; 89(12): 2165 doi: 10.1002/jmv.24849
8
Michael A. Chattergoon, Jordana S. Levine, Rachel Latanich, William O. Osburn, David L. Thomas, Andrea L. Cox. High Plasma Interleukin-18 Levels Mark the Acute Phase of Hepatitis C Virus InfectionThe Journal of Infectious Diseases 2011; 204(11): 1730 doi: 10.1093/infdis/jir642
9
Óscar Brochado-Kith, Alicia Gómez Sanz, Luis Miguel Real, Javier Crespo García, Pablo Ryan Murúa, Juan Macías, Joaquín Cabezas González, Jesús Troya, Juan Antonio Pineda, María Teresa Arias Loste, Victorino Díez Viñas, María Ángeles Jiménez-Sousa, Luz María Medrano de Dios, Isabel Cuesta De la Plaza, Sara Monzón Fernández, Salvador Resino García, Amanda Fernández-Rodríguez. MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV InfectionJournal of Clinical Medicine 2019; 8(6): 849 doi: 10.3390/jcm8060849
10
Claire Gondeau, Lydiane Pichard-Garcia, Patrick Maurel. Cellular models for the screening and development of anti-hepatitis C virus agentsPharmacology & Therapeutics 2009; 124(1): 1 doi: 10.1016/j.pharmthera.2009.05.010
11
C. Perales, N. M. Beach, I. Gallego, M. E. Soria, J. Quer, J. I. Esteban, C. Rice, E. Domingo, J. Sheldon. Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common PhenotypeJournal of Virology 2013; 87(13): 7593 doi: 10.1128/JVI.02824-12
12
Dengyuan Zhou, Qiuyan Li, Fan Jia, Luping Zhang, Shengfeng Wan, Yunchuan Li, Yunfeng Song, Huanchun Chen, Shengbo Cao, Jing Ye. The Japanese Encephalitis Virus NS1′ Protein Inhibits Type I IFN Production by Targeting MAVSThe Journal of Immunology 2020; 204(5): 1287 doi: 10.4049/jimmunol.1900946
13
J. M. P. Liefhebber, P. J. Hensbergen, A. M. Deelder, W. J. M. Spaan, H. C. van Leeuwen. Characterization of hepatitis C virus NS3 modifications in the context of replicationJournal of General Virology 2010; 91(4): 1013 doi: 10.1099/vir.0.016881-0
14
Smitha Kota, Virginia Takahashi, Feng Ni, John K. Snyder, A. Donny Strosberg, Gunnar F. Kaufmann. Direct Binding of a Hepatitis C Virus Inhibitor to the Viral Capsid ProteinPLoS ONE 2012; 7(2): e32207 doi: 10.1371/journal.pone.0032207
15
Yi Wang, Li Liu. The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Functions as a Novel Cytosolic Pathogen-Associated Molecular Pattern To Promote Beta Interferon Induction via a Toll-Like-Receptor-Related TRAF3-Independent MechanismmBio 2016; 7(1) doi: 10.1128/mBio.01872-15
16
Xiaowen Liu, Yulian Jiao, Xin Wen, Laicheng Wang, Chunyan Ma, Xuejun Gao, Zi-Jiang Chen, Yueran Zhao. Possible association of VISA gene polymorphisms with susceptibility to systemic lupus erythematosus in Chinese populationMolecular Biology Reports 2011; 38(7): 4583 doi: 10.1007/s11033-010-0590-4
17
Mohammed Asmal, Michael Seaman, Wenyu Lin, Raymond T Chung, Norman L Letvin, Ralf Geiben-Lynn. Inhibition of HCV by the serpin antithrombin IIIVirology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-226
18
Michael A. Joyce, Karyn M. Berry-Wynne, Theodore dos Santos, William R. Addison, Nicola McFarlane, Tom Hobman, D. Lorne Tyrrell, Glenn Randall. HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune responsePLOS Pathogens 2019; 15(8): e1007949 doi: 10.1371/journal.ppat.1007949
19
Arthur Donny Strosberg, Smitha Kota, Virginia Takahashi, John K. Snyder, Guillaume Mousseau. Core as a Novel Viral Target for Hepatitis C DrugsViruses 2010; 2(8): 1734 doi: 10.3390/v2081734
20
B. Cacopardo, G. Nunnari, L. Nigro. Clearance of HCV RNA following acute hepatitis A superinfectionDigestive and Liver Disease 2009; 41(5): 371 doi: 10.1016/j.dld.2007.11.015
21
Bianhong Zhang, Meng Li, Liang Chen, Kai Yang, Yufei Shan, Lianhui Zhu, Shaogang Sun, Lin Li, Chen Wang. The TAK1-JNK cascade is required for IRF3 function in the innate immune responseCell Research 2009; 19(4): 412 doi: 10.1038/cr.2009.8
22
Mario U. Mondelli, Stefania Varchetta, Francesco Negro. Liver Immunology2014; : 207 doi: 10.1007/978-3-319-02096-9_15
23
Doaa I. Hashad, Perihan E. Salem, Dina M. Abdallah. Toll like receptor 3 expression as a novel predictor of response to treatment in chronic hepatitis C virus patientsScandinavian Journal of Clinical and Laboratory Investigation 2011; 71(8): 641 doi: 10.3109/00365513.2011.624196
24
Scott J. Bergman, McKenzie C. Ferguson, Cathy Santanello. Interferons as Therapeutic Agents for Infectious DiseasesInfectious Disease Clinics of North America 2011; 25(4): 819 doi: 10.1016/j.idc.2011.07.008
25
Zachary P. Guinn, Thomas M. Petro. Interferon regulatory factor 3 plays a role in macrophage responses to interferon-γImmunobiology 2019; 224(4): 565 doi: 10.1016/j.imbio.2019.04.004
26
Carlo Ferrari, Valeria Barili, Stefania Varchetta, Mario U. Mondelli. The Liver2020; : 821 doi: 10.1002/9781119436812.ch63